Transdermal Buprenorphine, Opioid Rotation to Sublingual Buprenorphine, and the Avoidance of Precipitated Withdrawal

Authors

Keywords

Journal

Volume 22, Issue 3, Pages 199-205

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2013-07-11

DOI

10.1097/mjt.0b013e31828bfb6e

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started